Publications by authors named "Kyle A Robinson"

Claim this Profile
P
P2 pyridine N-oxide thrombin inhibitors: a novel peptidomimetic scaffold.
Philippe G Nantermet, Christopher S Burgey, Kyle A Robinson, Janetta M Pellicore, Christina L Newton

Bioorg Med Chem Lett· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic optimization of 3-amino-6-chloropyrazinone acetamide thrombin inhibitors. Implementation of P3 pyridine N-oxides to deliver an orally bioavailable series containing P1 N-benzylamides.
Christopher S Burgey, Kyle A Robinson, Terry A Lyle, Philippe G Nantermet, Harold G Selnick

Bioorg Med Chem Lett· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolism-directed optimization of 3-aminopyrazinone acetamide thrombin inhibitors. Development of an orally bioavailable series containing P1 and P3 pyridines.
Christopher S Burgey, Kyle A Robinson, Terry A Lyle, Philip E J Sanderson, S Dale Lewis

J Med Chem· February 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis